ReviewDermatology and therapy2024

Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review.

Miguel Mansilla-Polo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.